In fact, CHMP2B immunoreactive granules are observed as granulovacuolar degeneration in the brains of Parkinson’s disease, incidental Lewy body disease [35] and Alzheimer’s disease (AD) patients [36]. This evidence concerns the gene CHMP2B and Alzheimer disease.